Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo mri for detecting microbleeds

Stroke

Volumn 44, Issue 10, 2013, Pages 2782-2786

  Cheng, Ah Ling ^a   Batool, Saima ^a   McCreary, Cheryl R ^a   Lauzon, M L ^a   Frayne, Richard ^a   Goyal, Mayank ^a   Smith, Eric E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cerebral hemorrhage; Magnetic resonance imaging; Microbleeds

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CORRELATION COEFFICIENT; GRADIENT RECALLED ECHO IMAGING; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; RELIABILITY; SUSCEPTIBILITY WEIGHTED IMAGING; VASCULAR AMYLOIDOSIS;

CEREBRAL HEMORRHAGE; MAGNETIC RESONANCE IMAGING; MICROBLEEDS;

AGED; AGED, 80 AND OVER; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84888363777     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002267     Document Type: Article

References (23)

1. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2- weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20:637-642.
2. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol. 2009;8:165-174.
3. Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep. 2003;5:260-266.
4. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415-1420.
5. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68:1411-1416.
6. Charidimou A, Peeters A, Fox Z, Gregoire SM, Vandermeeren Y, Laloux P, et al. Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke. 2012;43:2324-2330.
7. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537-539.
8. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibilityweighted imaging: Technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 2009;30:19-30.
9. Tsui YK, Tsai FY, Hasso AN, Greensite F, Nguyen BV. Susceptibilityweighted imaging for differential diagnosis of cerebral vascular pathology: A pictorial review. J Neurol Sci. 2009;287:7-16.
10. Haacke EM, DelProposto ZS, Chaturvedi S, Sehgal V, Tenzer M, Neelavalli J, et al. Imaging cerebral amyloid angiopathy with susceptibility- weighted imaging. AJNR Am J Neuroradiol. 2007;28:316-317.
11. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility- weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol. 2009;30:338-343.
12. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: Technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 2009;30:232-252.
13. Goos JD, van der Flier WM, Knol DL, Pouwels PJ, Scheltens P, Barkhof F, et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke. 2011;42:1894-1900.
14. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, et al. improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke. 2009;40:94-99.
15. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73:1759-1766.
16. Dice LR. Measures of the amount of ecologic association between species. Ecology. 1945;26:297-302.
17. Greenberg SM, O'Donnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology. 1999;53:1135-1138.
18. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999;52:991-994.
19. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke. 2004;35:1831-1835.
20. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology. 2008;70:1208-1214.
21. Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, et al. Cerebral microbleeds, retinopathy, and dementia: The AGES-Reykjavik Study. Neurology. 2010;75:2221-2228.
22. Seghier ML, Kolanko MA, Leff AP, Jäger HR, Gregoire SM, Werring DJ. Microbleed detection using automated segmentation (MIDAS): A new method applicable to standard clinical MR images. PLoS One. 2011;6:e17547.
23. Liu T, Surapaneni K, Lou M, Cheng L, Spincemaille P, Wang Y. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology. 2012;262:269-278.